GU Research Network/Urology Cancer Center — Omaha, Nebraska

GU Research Network/Urology Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

GU Research Network/Urology Cancer Center has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Prostate Cancer, Renal Cell Carcinoma, Prostate Cancer Recurrent.

Sponsors: GU Research Network, LLC, Xynomic Pharmaceuticals, Inc., RhoVac APS.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GU Research Network/Urology Cancer Center?

GU Research Network/Urology Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GU Research Network/Urology Cancer Center conducted?

GU Research Network/Urology Cancer Center has 7 clinical trials on record, with 3 currently active. Their work covers Prostate Cancer, Renal Cell Carcinoma, Prostate Cancer Recurrent.

Is GU Research Network/Urology Cancer Center accredited by Crixeo Health?

Yes — GU Research Network/Urology Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about GU Research Network/Urology Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.